glutathione and triple negative breast cancer depletion dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative Mitochondrial Redox Vulnerabilities in Triple-Negative
Mitochondrial Redox Vulnerabilities in Triple Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




